These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1191 related articles for article (PubMed ID: 7114305)

  • 1. The Global Deterioration Scale for assessment of primary degenerative dementia.
    Reisberg B; Ferris SH; de Leon MJ; Crook T
    Am J Psychiatry; 1982 Sep; 139(9):1136-9. PubMed ID: 7114305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral disturbances of dementia in DSM-IV and ICD-10: fact or fiction?
    Zaudig M
    Int Psychogeriatr; 1996; 8 Suppl 3():285-8. PubMed ID: 9154577
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Global Deterioration Scale (GDS) and Functional Assessment Staging (FAST) in the diagnosis of Alzheimer type dementia].
    Krzymińska E; Rossa G; Krzymiński S
    Psychiatr Pol; 1993; 27(2):129-38. PubMed ID: 8378466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral disturbances of dementia: practical and conceptual issues.
    Rabins PV
    Int Psychogeriatr; 1996; 8 Suppl 3():281-3; discussion 289-91. PubMed ID: 9154576
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic classification of neuropsychiatric signs and symptoms in patients with dementia.
    Caine ED
    Int Psychogeriatr; 1996; 8 Suppl 3():273-9; discussion 289-91. PubMed ID: 9154575
    [No Abstract]   [Full Text] [Related]  

  • 6. [Presentation by the GRECO group of the French adaptation of a cognitive assessment scale used in Alzheimer type dementia].
    Puel M; Hugonot-Diener L
    Presse Med; 1996 Jun; 25(22):1028-32. PubMed ID: 8692788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging methods for the assessment of dementia: Perspectives.
    Cohen-Mansfield J; Reisberg B; Bonnema J; Berg L; Dastoor DP; Pfeffer RI; Cohen GD
    J Clin Psychiatry; 1996 May; 57(5):190-8. PubMed ID: 8626349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.
    O'Bryant SE; Waring SC; Cullum CM; Hall J; Lacritz L; Massman PJ; Lupo PJ; Reisch JS; Doody R;
    Arch Neurol; 2008 Aug; 65(8):1091-5. PubMed ID: 18695059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief screening tests versus clinical staging in senile dementia of the Alzheimer type.
    Davis PB; Morris JC; Grant E
    J Am Geriatr Soc; 1990 Feb; 38(2):129-35. PubMed ID: 2299116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between acquired impairments of executive function and behaviour change in adults with Down syndrome.
    Adams D; Oliver C
    J Intellect Disabil Res; 2010 May; 54(5):393-405. PubMed ID: 20367747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical picture of initial manifestations and the characteristics of the subsequent course of senile dementia].
    Kalyn IaB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):78-85. PubMed ID: 2609831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mini-Kingston Standardized Cognitive Assessment.
    Hopkins RW; Kilik LA
    Am J Alzheimers Dis Other Demen; 2013 May; 28(3):239-44. PubMed ID: 23543281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical scaling of the stages of cognitive decline in senile dementia.
    Overall JE; Scott J; Rhoades HM; Lesser J
    J Geriatr Psychiatry Neurol; 1990; 3(4):212-20. PubMed ID: 2073309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia. Initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia.
    Krishnan KR; Levy RM; Wagner HR; Chen G; Gersing K; Doraiswamy PM
    Psychopharmacol Bull; 2001; 35(3):79-88. PubMed ID: 12397880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of cognitive profiles in normal aging: implications for early manifestations of Alzheimer's disease.
    Mitrushina M; Uchiyama C; Satz P
    J Clin Exp Neuropsychol; 1995 May; 17(3):374-82. PubMed ID: 7650100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An empirical evaluation of the Global Deterioration Scale for staging Alzheimer's disease.
    Eisdorfer C; Cohen D; Paveza GJ; Ashford JW; Luchins DJ; Gorelick PB; Hirschman RS; Freels SA; Levy PS; Semla TP
    Am J Psychiatry; 1992 Feb; 149(2):190-4. PubMed ID: 1734738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable power of attorney and informed consent with Alzheimer's disease patients: a clinical study.
    Dukoff R; Sunderland T
    Am J Psychiatry; 1997 Aug; 154(8):1070-5. PubMed ID: 9247391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive changes in young-old adults: effect of family history of dementia.
    La Rue A; O'Hara R; Matsuyama SS; Jarvik LF
    J Clin Exp Neuropsychol; 1995 Feb; 17(1):65-70. PubMed ID: 7608303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cognitive deterioration in dementia: a two year longitudinal study.
    Chamberlain SR; Blackwell AD; Nathan PJ; Hammond G; Robbins TW; Hodges JR; Michael A; Semple JM; Bullmore ET; Sahakian BJ
    J Alzheimers Dis; 2011; 24(1):125-36. PubMed ID: 21206003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.